Clinical Trial Update: A Multi-Center Study to Evaluate the Efficacy and Safety of KX01 Ointment 1% on Actinic Keratosis on Face or Scalp [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial evaluating the efficacy and safety of KX01 Ointment 1% for actinic keratosis on the face or scalp has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• KX01 Ointment 1% (KX01 Ointment 1%)

Snippet

Sponsor: PharmaEssentia | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED